
-
'One of those days': Atletico record-breaker Sorloth hits four
-
Toulouse's Ntamack suffers concussion in Top 14, Willemse nears exit
-
Record-breaker Sorloth hits four as Atletico smash Real Sociedad
-
'Weight off my shoulders': Bayern's Kane toasts breakthrough title
-
Sinner grateful for 'amazing' support on Italian Open return from doping ban
-
Hamburg return to Bundesliga after seven-year absence
-
Toulouse's Ntamack suffers concussion in Top 14 clash
-
India, Pakistan reach ceasefire -- but trade claims of violations
-
'Long time coming': Bayern's Kane toasts breakthrough title
-
US, China conclude first day of trade talks in Geneva
-
Kane tastes first title as champions Bayern bid farewell to Mueller
-
Benfica deny Sporting to take Portuguese title race to wire
-
Sinner makes triumphant return from doping ban at Italian Open
-
Sinner wins at Italian Open in first match since doping ban
-
Leo XIV, new pope and 'humble servant of God', visits Francis's tomb
-
India claims Pakistan violated truce, says it is retaliating
-
Champions League race hots up as Man City held, Villa win
-
Kane tastes first title as champions Bayern see off Mueller
-
US envoy calls enrichment 'red line' ahead of new Iran talks
-
Hastoy lifts La Rochelle as Castres pay tribute to Raisuqe
-
Southampton avoid Premier League 'worst-ever' tag with Man City draw
-
Injury forces Saints quarterback Carr to retire
-
S.Korea conservative party reinstates candidate after day of turmoil
-
Verdict due Tuesday in Depardieu sexual assault trial
-
Man City held by Southampton as Brentford, Brighton win
-
Groundbreaking Cameroonian curator Kouoh dies: Cape Town art museum
-
Leo XIV, 'humble servant of God', visits sanctuary in first papal outing
-
Leipzig miss Champions League as Bochum and Kiel relegated
-
Tarling wins Giro time trial in Tirana, Roglic in pink
-
US and China meet in 'important step' towards de-escalating trade war
-
Champions Chelsea finish WSL season unbeaten
-
At his former US university, the new pope is just 'Bob'
-
Ukraine allies set ultimatum to Russia for 30-day ceasefire
-
Deja vu in France as Marc Marquez beats brother Alex in MotoGP sprint
-
Alonso has 'every door open': Real Madrid's Ancelotti
-
Swiatek's Rome title defence ends early as Sinner set for hero's return
-
Marc Marquez wins French MotoGP sprint race
-
Swiatek's Italian Open title defence ended early by Collins
-
Uproar as S. Korea conservatives switch presidential candidate
-
Vollering retains women's Vuelta title in style
-
India and Pakistan agree to ceasefire after days of attacks
-
Pope Leo XIV says choice of name reflects social commitment
-
Ecuador declares national mourning for 11 troops killed by guerrillas
-
Thousands in Spain confined indoors for hours by toxic fumes
-
Postecoglou 'hopeful' Son will return for Spurs against Palace
-
Ukraine, Europe allies seek 30-day Russia truce starting Monday
-
Flick wants 'dominant' Barca in vital Liga Clasico
-
Panicked Indians flee Kashmir city on special train
-
With papacy, Leo XIV inherits Vatican money troubles
-
Quartararo pips Marquez brothers to pole at home French MotoGP

Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
P.Martin--AMWN